- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00910910 | Active, not recruiting Has Results |
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
450 | All | 65 Years and older (Adult, Senior) | NCT00910910 | CC-5013-CLL-008 2008-003079-32 |
ORIGIN | October 13, 2009 | March 31, 2014 | April 30, 2018 | June 1, 2009 | October 2, 2017 | December 21, 2016 |
|